Evaluation of Potential Antidepressant Activity of <i>Laserpitium Latifolium </i>Plant: <i>In Silico</i> Molecular Docking, ADMET And <i>In Vivo</i> Analysis
Background: Globally, depression affects over 300 million people and is a leading cause of disability, yet current synthetic antidepressants often come with significant side effects such as weight gain, sexual dysfunction, and insomnia or suffer from a slow onset of action. This has driven a search for safer, plant-derived alternatives that can modulate the monoaminergic system (serotonin, norepinephrine, and dopamine) or target the neuro-inflammatory pathways. Aim: This study aims to investigate the antidepressant potential of an Ethanolic Extract of Laserpitium latifolium L (EELL). Methods: The plant material was extracted by maceration using ethanol as solvent. The obtained EELL was analysed by Gas Chromatography � Mass Spectrometry (GC-MS) to identify the active phytoconstituents. The selected phytoconstituents were selected as ligands, and human monoamine oxidase A (2Z5Y) was selected as the protein. Docking studies were performed, and finally, the extraction was used to perform in vivo antidepressant activity by using the Forced Swim Test (FST) and Tail Suspension method. Results: 29 compounds were identified through GC-MS analysis and in silico docking studies performed for 8 compounds using Monoamine Oxidase A (MAO-A; PDB ID: 2Z5Y) protein. out of 8 compounds, Blebbistatin exhibited superior binding affinity (-10.2 kcal/mol) compared to the standard MAO-A inhibitor, Imipramine (-8.0 kcal/mol). In the in vivo antidepressant study, 24 male Wistar albino rats were randomly divided into four groups: Group I (Normal control), Group II (Standard Imipramine, 10mg/kg), and Groups III and IV (Treatment groups, 200 and 400mg/kg, respectively). No morbidity and mortality were observed up to the dose of 2000 mg/kg. The antidepressant results showed that the extract significantly reduced immobility time in both the Forced Swim Test (FST) and Tail Suspension Test (TST) at doses of 200 and 400 mg/kg. Conclusion: The above findings suggest that L. latifolium L. exhibits ant